Bridge to Life has received FDA De Novo clearance for its VitaSmart hypothermic oxygenated perfusion (HOPE) system for liver ...

ANDOVER, Mass., Aug. 2, 2023 /PRNewswire/ -- TransMedics Group, Inc. (TMDX) ("TransMedics"), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung ...

WALTHAM, Mass.--(BUSINESS WIRE)--Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the completion of the world’s first donor kidney ...

Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...

New Modes Are Beginning to Gain Ground on Fed-batch Strategy The therapeutic success of highly efficacious complex biologicals that are almost exclusively produced in cell culture such as antibodies ...

27 April 2025, Boston—In places like Australia, where metropolitan areas are separated by an entire continent, donor hearts used to go unused simply because transplant teams couldn’t get the organ to ...

WALTHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Paragonix Technologies, a leader in advanced organ preservation and transplant logistics, reports an extraordinary case at the Tampa General Hospital ...

The donated systems are an investigational medical device in the United States and have not been approved or cleared by the U.S. Food and Drug Administration (FDA) for sale or distribution. NIRSense ...

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.

Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...